Page 198 - Read Online

Sazonova et al. Threshold heteroplasmy levels of atherogenic mutations

on behalf of the advisory board of the 3rd, 4th and 5th watching the 36. Fondevila M, Børsting C, Phillips C, de la Puente M, Consortium
risk symposia, at the 13th, 15th and 20th European Stroke Conferences, EN, Carracedo A, Morling N, Lareu MV. Forensic SNP genotyping
Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, with SNaPshot: technical considerations for the development and
Germany, 2011. Cerebrovasc Dis 2012;34:290-6. optimization of multiplexed SNP assays. Forensic Sci Rev 2017;29:57-
27. Amato M, Veglia F, de Faire U, Giral P, Rauramaa R, Smit AJ, 76.
Kurl S, Ravani A, Frigerio B, Sansaro D, Bonomi A, Tedesco CC, 37. Salimullah M, Hamano K, Tachibana M, Inoue K, Nishigaki K.
Castelnuovo S, Mannarino E, Humphries SE, Hamsten A, Tremoli Efficient SNP analysis enabled by joint application of the muTGGE
E, Baldassarre D; IMPROVE study group. Carotid plaque-thickness and heteroduplex methods. Cell Mol Biol Lett 2005;10:237-45.
and common carotid IMT show additive value in cardiovascular risk 38. Sazonova MA, Shkurat TP, Demakova NA, Zhelankin AV, Barinova
prediction and reclassification. Atherosclerosis 2017;263:412-9. VA, Sobenin IA, Orekhov AN. Mitochondrial genome sequencing in
28. Sobenin IA, Zhelankin AV, Mitrofanov KY, Sinyov VV, Sazonova atherosclerosis: what’s next? Curr Pharm Des 2016;22:390-6.
MA, Postnov AY, Orekhov AN. Mutations of mitochondrial DNA in 39. Ladouceur M, Zheng HF, Greenwood CM, Richards JB. Empirical
atherosclerosis and atherosclerosis-related diseases. Curr Pharm Des power of very rare variants for common traits and disease: results from
2015;21:1158-63. sanger sequencing 1998 individuals. Eur J Hum Genet 2013;21:1027-
29. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning : a laboratory 30.
manual. Cold Spring Harbor: Cold Spring Harbor Laboratory; 1982. 40. Georghiou SB, Seifert M, Lin SY, Catanzaro D, Garfein RS, Jackson
30. Zhang XX, Li MR, Cao Y, Zhang RW, Zhang Y, Li F, Xi HL, Xu XY. RL, Crudu V, Rodrigues C, Victor TC, Catanzaro A, Rodwell TC.
Dynamics of genotypic mutations of the hepatitis B virus associated Shedding light on the performance of a pyrosequencing assay for
with long-term entecavir treatment determined with ultradeep drug-resistant tuberculosis diagnosis. BMC Infect Dis 2016;16:458.
pyrosequencing: a retrospective observational study. Medicine 41. Yeo MK, Jung MK, Lee SY, Lee YM, Hur GM, Kim JM. The
(Baltimore) 2016;95:e2614. usefulness of a novel fully automated PCR-based Idylla test for
31. Harrington CT, Lin EI, Olson MT, Eshleman JR. Fundamentals of detection of the BRAF V600E mutation in thyroid tissue: comparison
pyrosequencing. Arch Pathol Lab Med 2013;137:1296-303. with PNA-clamping PCR, real-time PCR and pyrosequencing. J Clin
32. Kreutz M, Schock G, Kaiser J, Hochstein N, Peist R. PyroMark® Pathol 2017;70:260-5.
instruments, chemistry, and software for Pyrosequencing® analysis. 42. Mohamed S, Bourliere M, Benali S, Oules V, Castellani P, Khiri H,
Methods Mol Biol 2015;1315:17-27. Camus C, Penaranda G, Chiche L, Gonzalez D, Sayada C, Olive D,
33. Rajatileka S, Luyt K, Williams M, Harding D, Odd D, Molnár Halfon P. Clinical relevance of the HCV protease inhibitor-resistant
E, Váradi A. Detection of three closely located single nucleotide mutant viral load assessed by ultra-deep pyrosequencing in treatment
polymorphisms in the EAAT2 promoter: comparison of single-strand failure. J Clin Virol 2016;78:36-43.
conformational polymorphism (SSCP), pyrosequencing and Sanger 43. Pu D, Mao C, Cui L, Shi Z, Xiao P. Pyrosequencing with di-base
sequencing. BMC Genet 2014;15:80. addition for single nucleotide polymorphism genotyping. Anal
34. Simou M, Kouskouni E, Vitoratos N, Economou E, Creatsas G. Bioanal Chem 2016;408:3113-23.
Polymorphisms of platelet glycoprotein receptors and cell adhesion 44. Kuscu C, Kuscu C. Pyrosequencing analysis for breast cancer DNA
molecules in fetuses with fetal growth restriction and their mothers as methylome. Methods Mol Biol 2016;1406:89-104.
detected with pyrosequencing. In Vivo 2017;31:243-9. 45. Matsunaga H, Tanaka Y, Tanaka M, Gong JS, Zhang J, Nomiyama
35. Mahmood U, Imran M, Naik SI, Cheema HA, Saeed A, Arshad M, T, Ogawa O, Ogihara T, Yamada Y, Yagi K, Kawamori R.
Mahmood S. Detection of common mutations in the GALT gene Antiatherogenic mitochondrial genotype in patients with type 2
through ARMS. Gene 2012;509:291-4. diabetes. Diabetes Care 2001;24:500-3.

Vessel Plus ¦ Volume 1 ¦ December 28, 2017 191